155 related articles for article (PubMed ID: 31278126)
1. Inhibition of breast cancer cells by targeting E2F-1 gene and expressing IL15 oncolytic adenovirus.
Yan Y; Xu H; Wang J; Wu X; Wen W; Liang Y; Wang L; Liu F; Du X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31278126
[TBL] [Abstract][Full Text] [Related]
2. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.
Yan Y; Li S; Jia T; Du X; Xu Y; Zhao Y; Li L; Liang K; Liang W; Sun H; Li R
Tumour Biol; 2015 Jun; 36(6):4535-43. PubMed ID: 25627006
[TBL] [Abstract][Full Text] [Related]
4. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
5. Targeting human breast cancer cells by an oncolytic adenovirus using microRNA-targeting strategy.
Shayestehpour M; Moghim S; Salimi V; Jalilvand S; Yavarian J; Romani B; Mokhtari-Azad T
Virus Res; 2017 Aug; 240():207-214. PubMed ID: 28867494
[TBL] [Abstract][Full Text] [Related]
6. Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model.
Yan Y; Xu Y; Zhao Y; Li L; Sun P; Liu H; Fan Q; Liang K; Liang W; Sun H; Du X; Li R
Tumour Biol; 2014 Feb; 35(2):1113-22. PubMed ID: 24037896
[TBL] [Abstract][Full Text] [Related]
7. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic Adenovirus rAd.DCN Inhibits Breast Tumor Growth and Lung Metastasis in an Immune-Competent Orthotopic Xenograft Model.
Zhao H; Wang H; Kong F; Xu W; Wang T; Xiao F; Wang L; Huang D; Seth P; Yang Y; Wang H
Hum Gene Ther; 2019 Feb; 30(2):197-210. PubMed ID: 30032645
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.
Gomez-Gutierrez JG; Rao XM; Zhou HS; McMasters KM
Virology; 2012 Nov; 433(2):538-47. PubMed ID: 23021422
[TBL] [Abstract][Full Text] [Related]
10. Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway.
Cascallo M; Alonso MM; Rojas JJ; Perez-Gimenez A; Fueyo J; Alemany R
Mol Ther; 2007 Sep; 15(9):1607-15. PubMed ID: 17579575
[TBL] [Abstract][Full Text] [Related]
11. A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses.
Rojas JJ; Cascallo M; Guedan S; Gros A; Martinez-Quintanilla J; Hemminki A; Alemany R
Gene Ther; 2009 Dec; 16(12):1441-51. PubMed ID: 19710704
[TBL] [Abstract][Full Text] [Related]
12. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenovirus armed with IL-24 inhibits the growth of breast cancer in vitro and in vivo.
Zhu W; Wei L; Zhang H; Chen J; Qin X
J Exp Clin Cancer Res; 2012 May; 31(1):51. PubMed ID: 22640485
[TBL] [Abstract][Full Text] [Related]
14. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
15. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo.
Dong X; Qu W; Ma S; Zhu Z; Zheng C; He A; Karlsson A; Xu K; Zheng X
Cancer Lett; 2013 Jan; 328(1):95-103. PubMed ID: 23000515
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
[TBL] [Abstract][Full Text] [Related]
18. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.
Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X
Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824
[TBL] [Abstract][Full Text] [Related]
19. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
[TBL] [Abstract][Full Text] [Related]
20. Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD.
Majem M; Cascallo M; Bayo-Puxan N; Mesia R; Germa JR; Alemany R
Cancer Gene Ther; 2006 Jul; 13(7):696-705. PubMed ID: 16498429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]